Home Department: Bioengineering
Supported by: Anonymous Donor
Mentor: Sharon Pitteri, Radiology

Alisha is investigating small molecule drugs that are potent against breast cancer cell lines using quantitative proteomics technology. She will compare treated and untreated cells to identify which proteins have altered levels in the treated cells. The experiment is being conducted to gain a deeper understanding of what proteins and pathways these drugs are targeting, in order to design more potent analogs that will ultimately be more successful in killing breast cancer cells.

Poster presented at the Stanford Bio-X Interdisciplinary Initiatives Symposium on August 24, 2017:

Elucidating the Biological Targets and Pathways of Novel Drugs in Breast Cancer

Alisha Birk¹, Catherine Going¹, Vineet Kumar², Sanjay Malhotra², Sharon Pitteri¹
[Departments of Radiology¹ and Radiation Oncology², Stanford University]